Molecular diagnostic tests can involve high costs due to the specialized equipment, proprietary reagents, advanced laboratory infrastructure, and skilled personnel required to run and interpret complex genetic assays. However, their ability to provide targeted diagnoses often reduces overall long-term healthcare spending by preventing ineffective treatments.